# Dana-Farber trial of the Paxman limb cryocompression system

Source: https://onco.cc/trials/dfci-paxman-limb-cryocompression/  
OnCo record `dfci-paxman-limb-cryocompression` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A US study testing Paxman's machine that cools and squeezes the hands and feet during taxane chemotherapy to prevent nerve damage.

## Summary

The Dana-Farber study plans 50 participants and lists taxane-induced peripheral neuropathy as its condition, with the Paxman Limb Cryocompression System as the intervention. ClinicalTrials.gov gives an estimated primary completion in August 2027.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-11-04
- Also known as: Cryocompression for CIPN
- Tags: machines-wave3
- Registry id: NCT07064798
- Phase: not-applicable
- Setting: Patients receiving taxane chemotherapy, using the Paxman Limb Cryocompression System to prevent peripheral neuropathy
- Sponsor: Dana-Farber Cancer Institute
- Enrolled: 50

## Sources

- ClinicalTrials.gov NCT07064798: https://clinicaltrials.gov/study/NCT07064798
- Paxman: the Paxman Neuropathy System (limb cryocompression): https://paxmangroup.com/reduce-nerve-damage/paxman-neuropathy/

## Connected records

- technologies: [Limb cryocompression devices for chemotherapy nerve damage (Paxman Neuropathy System, Hilotherm ChemoCare)](https://onco.cc/technologies/limb-cryocompression-devices/)
- drugs: [Docetaxel](https://onco.cc/drugs/docetaxel/), [Paclitaxel / nab-paclitaxel](https://onco.cc/drugs/paclitaxel/)
- companies: [Paxman](https://onco.cc/companies/paxman/)
- institutions: [Dana-Farber Brigham Cancer Center](https://onco.cc/institutions/dana-farber/)

---
JSON: https://onco.cc/api/v1/entities/dfci-paxman-limb-cryocompression.json